Skip to main content
Clinical Trials/NCT06251167
NCT06251167
Recruiting
Not Applicable

A Multi-centre Feasibility Study Assessing Shoe-worn Insoles to Improve Clinical and Biomechanical Features of Knee Osteoarthritis

University of British Columbia1 site in 1 country36 target enrollmentMarch 4, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Knee Osteoarthritis
Sponsor
University of British Columbia
Enrollment
36
Locations
1
Primary Endpoint
Recruitment - number of screened patients who are eligible
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

Shoe-worn insoles (also known as orthotics) can provide symptomatic relief for people with knee osteoarthritis. However, given they act at the feet, and given that many people with knee osteoarthritis also report foot pain, it is important to assess the effects of these devices at both joints. We will conduct a multi-centre randomized pilot trial to determine feasibility and preliminary efficacy.

Registry
clinicaltrials.gov
Start Date
March 4, 2024
End Date
December 31, 2025
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Michael Hunt

Professor

University of British Columbia

Eligibility Criteria

Inclusion Criteria

  • medial tibiofemoral OA defined as definitive osteophytes and joint space narrowing in the medial compartment, as confirmed with radiographs
  • history of knee pain longer than 6 months
  • average self-reported knee pain of at least 3 out of 10 (using an 11-point numerical rating scale with terminal descriptors of 0 = "no pain" and 10 = "worst pain imaginable") over the 6 months prior to baseline testing
  • pain in the same foot/feet as the painful knee(s)
  • ability to communicate in English
  • show an immediate biomechanical response to the insoles. This final eligibility criterion will be determined from an in-person biomechanical assessment after participants have passed all previous eligibility screening.

Exclusion Criteria

  • radiographic evidence of more lateral tibiofemoral OA than medial
  • knee surgery or intra-articular injection within the previous 6 months
  • current or recent (within 6 months) corticosteroid use for any reason
  • presence of a systemic arthritic condition
  • history of knee joint replacement or tibial osteotomy
  • any other condition affecting lower limb function
  • current usage of shoe-worn insoles, or planning to acquire footwear modifications in the next 6 months
  • any previous experience with insoles that resulted in increased lower limb pain or a self- or clinician-initiated termination of use.

Outcomes

Primary Outcomes

Recruitment - number of screened patients who are eligible

Time Frame: from onset of recruitment through study completion

The number of screened patients determined eligible to be enrolled in the study.

Retention - proportion of assessments with complete outcome measures data

Time Frame: immediately after the intervention

Proportion of assessments with complete outcome measures data out of total number of assessments in the study protocol.

Self-reported foot pain

Time Frame: Baseline, 3 Months

Foot pain will be measured at baseline and at 3-months by the Pain subscale (7 items) of the Foot Function Index revised short form (FFI-RS). This is a self-report questionnaire consisting of 34 items that provides the ability to quantify aspects of foot pain, disability and activity limitation.

External knee adduction moment impulse

Time Frame: Baseline, 3 Months

The external knee adduction moment impulse will be calculated. Participants will walk on an instrumented walkway (embedded force platform(s)) while high speed cameras track the trajectories of markers placed on bony landmarks. Moments will be calculated using an inverse dynamics approach.

Insoles Delivery

Time Frame: from date of insoles ordering until date of delivery to the laboratory, assessed up to 3 months

Time between foot scan assessment and delivery of insoles. Given that insoles will be manufactured centrally and distributed to the sites, we are interested in assessing the expected timeframe for enrollment in the study.

Self-reported knee pain

Time Frame: Baseline, 3 Months

Knee pain will be measured by the Pain subscale (9 items) of the Knee Injury and Osteoarthritis Outcome Score (KOOS) at baseline and at 3-months. Each item is rated on a 5 points Likert scale where 0 = "No problems" and 4 = "Extreme Problems". Higher scores indicate better function. The scores are normalized to 0-100%.

Secondary Outcomes

  • External knee flexion moment impulse(Baseline, 3 Months)
  • Rearfoot eversion peak(Baseline, 3 Months)
  • Self-selected gait speed(Baseline, 3 Months)
  • Self-reported foot function(Baseline, 3 Months)
  • Self-reported overall physical function(Baseline, 3 Months)

Study Sites (1)

Loading locations...

Similar Trials